Carcinogenesis Advance Access published online on January 7, 2006
Carcinogenesis, doi:10.1093/carcin/bgi343
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Cellular and Molecular Physiology, The Milton S. Hershey Medical Center, The Pennsylvania State University College of Medicine, Hershey, PA 17033
* To whom correspondence should be addressed. To test the hypothesis that suppression of ornithine decarboxylase (ODC) activity blocks the promotion of target cells in the outer root sheath of the hair follicle initiated by Raf/MEK/ERK activation, we crossed mice overexpressing an activated MEK mutant in the skin (K14-MEK mice) with two transgenic lines overexpressing antizyme (AZ), which binds to ODC and targets it for degradation. K14-MEK mice develop spontaneous skin tumors without initiation or promotion. These mice on the ICR background were crossed with K5-AZ and K6-AZ mice on both the carcinogenesis-resistant C57BL/6 background and the sensitive DBA/2 background. Expression of AZ driven by either the K5 or K6 promoter along with K14-MEK dramatically delayed tumor incidence and reduced tumor multiplicity on both backgrounds compared to littermates expressing the MEK transgene alone. The effect was most remarkable in the MEK/K6-AZ mice from the ICR/D2 F1 cross, where double transgenic mice averaged less than one tumor per mouse for more than 8 weeks, while K14-MEK mice averaged over 13 tumors per mouse at this age. Putrescine was decreased in MEK/AZ tumors, while spermidine and spermine levels were unaffected, suggesting that the primary role played by AZ in this system is to inhibit putrescine accumulation. MEK/AZ tumors did not show evidence of apoptosis, but there was a 15-20% decrease in S-phase cells and a 40-60% decrease in mitotic cells in MEK/AZ tumors. These results indicate that the principal effect of AZ may be to slow cell growth primarily by increasing G2/M transit time.
Received August 4, 2005
Revised December 23, 2005
Accepted December 29, 2005
CARCINOGENESIS
Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis1
David J. Feith 1,
Sofia Origanti 1,
Paula L. Shoop 1,
Suzanne Sass-Kuhn 1,
and
Lisa M. Shantz 1 *
Lisa M. Shantz, E-mail: lms17{at}psu.edu
Abstract
1This work was supported by grant CA-82768 from the NCI (L.M.S.)
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  X. Wang, D. J. Feith, P. Welsh, C. S. Coleman, C. Lopez, P. M. Woster, T. G. O'Brien, and A. E. Pegg Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis Carcinogenesis, November 1, 2007; 28(11): 2404 - 2411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Origanti and L. M. Shantz Ras Transformation of RIE-1 Cells Activates Cap-Independent Translation of Ornithine Decarboxylase: Regulation by the Raf/MEK/ERK and Phosphatidylinositol 3-Kinase Pathways Cancer Res., May 15, 2007; 67(10): 4834 - 4842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. P. Ivanov and J. F. Atkins Ribosomal frameshifting in decoding antizyme mRNAs from yeast and protists to humans: close to 300 cases reveal remarkable diversity despite underlying conservation Nucleic Acids Res., March 19, 2007; 35(6): 1842 - 1858. [Abstract] [Full Text] [PDF]
|
|